Benzinga's Top Initiations

By: via Benzinga
Analysts at H.C. Wainwright initiated coverage of Cara Therapeutics Inc (NASDAQ: CARA) with a Buy rating. The price ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.